Opportunity Information: Apply for PAR 12 144
Apply for PAR 12 144
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NCI Small Grants Program for Cancer Research (NCI Omnibus R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research.
- This funding opportunity was created on Aug 8, 2013 and posted on Mar 29, 2012.
- Applicants must submit their applications by Nov 18, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Special district governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Small businesses Independent school districts Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) City or township governments Public and State controlled institutions of higher education For profit organizations other than small businesses State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NCI Small Grants Program for Cancer Research (NCI Omnibus R03), Funding Opportunity Number PAR-12-144, is a National Institutes of Health (NIH) grant opportunity run through the National Cancer Institute (NCI) that is designed to support smaller, focused cancer research projects that can be completed relatively quickly and with limited resources. It uses the NIH R03 mechanism, which is commonly used for early-stage or narrowly scoped studies where investigators need modest support to generate initial findings, test an idea, refine an approach, or produce data that can later justify a larger, more comprehensive grant application.
The purpose of this announcement is to encourage a wide range of short-duration cancer-related projects rather than a single narrow research theme. The FOA explicitly highlights several types of work that fit well under an R03: pilot and feasibility studies that test whether an approach is workable; secondary analyses of existing datasets that can produce new insights without collecting new data from scratch; small, self-contained projects with a clear and limited set of aims; development or refinement of research methods; and development of new research technologies. In practice, that means the program is well-suited to projects that are high-value but not resource-intensive, such as validating a new measurement approach, exploring an understudied hypothesis using archived samples or existing data, building or stress-testing an analytic pipeline, or establishing preliminary performance for a new tool or assay relevant to cancer research.
From a subject-area standpoint, the FOA falls under multiple cancer research CFDA listings, reflecting the breadth of what NCI is willing to support through this omnibus mechanism. The CFDA numbers associated with the opportunity include 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), and 93.396 (Cancer Biology Research). This signals that eligible projects can span the cancer research continuum, from etiology and prevention through detection, diagnosis, treatment, and fundamental biology, as long as the work fits the small-grant scope and aligns with NCI priorities for advancing cancer research.
Administratively, this is a discretionary grant program and does not require cost sharing or matching, which reduces barriers for applicants that may not have access to institutional or third-party matching funds. The opportunity was originally posted on March 29, 2012, with the record showing a creation date of August 8, 2013. The original closing date was listed as September 7, 2015, though the record also includes a current closing date of November 18, 2013, and an archive date of December 19, 2013. Those dates indicate the listing as provided is historical/archived, and anyone looking to apply would need to confirm the current availability of the mechanism or locate the most recent active R03 omnibus announcement on the NIH grants site.
Eligibility is broad and includes many kinds of U.S. and non-U.S. organizations. Eligible applicants listed include federal, state, local, and regional government entities (such as state governments, county governments, and city or township governments), special district governments, and public housing authorities/Indian housing authorities. Academic institutions are eligible as well, including public and state-controlled institutions of higher education, private institutions of higher education, independent school districts, and minority-serving institutions and mission-driven institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and other tribal and community-focused organizations. Nonprofit organizations are eligible whether they have 501(c)(3) status or not (as long as they are not institutions of higher education in that nonprofit category listing), and for-profit entities are also eligible, including small businesses and other for-profit organizations. The FOA also makes clear that non-domestic (non-U.S.) entities (foreign institutions) may apply, non-domestic components of U.S. organizations may apply, and foreign components are allowed as defined by NIH policy, which is important for international collaborations or projects that require specialized foreign cohorts, datasets, or technical capabilities.
For applicants or institutions that need help accessing the full announcement or encounter technical issues, the listing provides a standard NIH Office of Extramural Research (OER) contact point via the OER webmaster (FBOWebmaster@OD.NIH.GOV). The full announcement was hosted on the NIH grants guide site at http://grants.nih.gov/grants/guide/pa-files/PAR-12-144.html, which typically contains the official details that govern application structure, budget limits, project period expectations, review criteria, and any NCI- or NIH-specific submission requirements tied to the R03 mechanism.
Overall, this FOA is best understood as a flexible entry point for cancer researchers who have a well-defined, limited-scope question and a plan that can reasonably be completed quickly, especially when the work is exploratory, method-building, technology-enabling, or based on existing data resources. It is also structured to accommodate a wide variety of institution types, including international applicants, reflecting NCI and NIH interest in enabling smaller but meaningful advances that can seed larger future studies.
FAQs: NCI Small Grants Program for Cancer Research (NCI Omnibus R03) - PAR-12-144
What is the NCI Small Grants Program for Cancer Research (NCI Omnibus R03)?
It is a National Institutes of Health (NIH) funding opportunity run through the National Cancer Institute (NCI) that supports smaller, focused cancer research projects designed to be completed relatively quickly and with limited resources. It uses the NIH R03 grant mechanism.
What is the Funding Opportunity Number for this grant?
The Funding Opportunity Number is PAR-12-144.
What does "Omnibus R03" mean in this context?
In this announcement, "omnibus" refers to a flexible, broad program that encourages a wide range of short-duration cancer-related projects rather than focusing on a single narrow research theme.
What kinds of projects are a good fit for the NIH R03 mechanism under this FOA?
The FOA highlights several project types that fit well under an R03, including pilot and feasibility studies, secondary analyses of existing datasets, small self-contained projects with limited aims, development or refinement of research methods, and development of new research technologies relevant to cancer research.
Is this grant intended for large, multi-year cancer studies?
No. The R03 mechanism is described here as supporting modest, narrowly scoped or early-stage studies that can be completed relatively quickly and with limited resources.
What are examples of activities that could align with this FOA?
Examples described as a good match include validating a new measurement approach, exploring an understudied hypothesis using archived samples or existing data, building or stress-testing an analytic pipeline, refining a research method, or establishing preliminary performance for a new tool or assay relevant to cancer research.
Does the FOA limit applications to a single cancer topic area?
No. The stated purpose is to encourage a wide range of short-duration cancer-related projects rather than a single narrow research theme.
What cancer research areas are covered by this opportunity?
The listing indicates broad coverage across the cancer research continuum, including etiology and prevention, detection and diagnosis, treatment, and fundamental cancer biology, as long as the work fits the small-grant scope and aligns with NCI priorities.
What CFDA numbers are associated with this opportunity?
The CFDA numbers listed are 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), and 93.396 (Cancer Biology Research).
Is cost sharing or matching required?
No. The program is described as a discretionary grant program that does not require cost sharing or matching.
Who runs this grant program?
This NIH grant opportunity is run through the National Cancer Institute (NCI).
Is eligibility limited to U.S. organizations?
No. The FOA states that non-domestic (non-U.S.) entities (foreign institutions) may apply, non-domestic components of U.S. organizations may apply, and foreign components are allowed as defined by NIH policy.
What types of U.S. government entities are listed as eligible applicants?
The eligible applicant types include federal, state, local, and regional government entities (such as state governments, county governments, and city or township governments), special district governments, and public housing authorities/Indian housing authorities.
Are academic institutions eligible to apply?
Yes. The eligibility list includes public and state-controlled institutions of higher education, private institutions of higher education, independent school districts, and minority-serving and mission-driven institutions.
Which minority-serving or mission-driven institutions are specifically mentioned as eligible?
The listing specifically mentions Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, and Tribally Controlled Colleges and Universities (TCCUs), along with other tribal and community-focused organizations.
Are nonprofit organizations eligible?
Yes. Nonprofit organizations are listed as eligible whether they have 501(c)(3) status or not, as described in the eligibility section provided.
Are for-profit organizations eligible?
Yes. For-profit entities are eligible, including small businesses and other for-profit organizations.
Is this funding opportunity still open?
The dates shown in the listing indicate it is historical/archived. The record includes multiple dates (including closing dates and an archive date), which suggests anyone interested in applying should confirm current availability or locate the most recent active NCI/NIH R03 omnibus announcement on the NIH grants site.
What dates are shown in the listing for this opportunity?
The listing notes the opportunity was originally posted March 29, 2012, shows a creation date of August 8, 2013, includes an original closing date of September 7, 2015, also shows a current closing date of November 18, 2013, and lists an archive date of December 19, 2013.
Where can the full official announcement be found?
The full announcement is hosted on the NIH Grants Guide site at: http://grants.nih.gov/grants/guide/pa-files/PAR-12-144.html
Who should be contacted for help accessing the announcement or resolving technical issues?
The listing provides a contact point via the NIH Office of Extramural Research (OER) webmaster: FBOWebmaster@OD.NIH.GOV
What is the overall goal of this FOA for applicants?
It is positioned as an entry point for cancer researchers with a well-defined, limited-scope question and a plan that can be completed quickly, especially for exploratory work, method-building, technology-enabling projects, or studies based on existing data resources that may support future larger applications.
Browse more opportunities from the same category: Education Health
Next opportunity: Ridgefield NWR Education and Outreach
Previous opportunity: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 144
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 144) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanisms of Alcohol associated Cancers (R01) Apply for PA 12 146 Funding Number: PA 12 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol associated Cancers (R21) Apply for PA 12 147 Funding Number: PA 12 147 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Senior Scientist Research Award (K05) Apply for PA 12 048 Funding Number: PA 12 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| A Data Resource for Analyzing Blood and Marrow Transplants (Limited Competition U24) Apply for RFA CA 12 503 Funding Number: RFA CA 12 503 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Target Discovery and Development (CTDD) Network (U01) Apply for RFA CA 12 006 Funding Number: RFA CA 12 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| U.S. China Program for Biomedical Collaborative Research (R01) Apply for RFA AI 12 021 Funding Number: RFA AI 12 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| NLM Administrative Supplements for Informationist Services in NIH funded Research Projects (Admin Supp) Apply for PA 12 158 Funding Number: PA 12 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Senior Scientist Research Award (K05) Apply for PA 12 148 Funding Number: PA 12 148 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Research on HIV Persistence (R21) Apply for PA 12 162 Funding Number: PA 12 162 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Basic Research on HIV Persistence (R01) Apply for PA 12 161 Funding Number: PA 12 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Sequencing Exploratory Research (U01) Apply for RFA HG 12 009 Funding Number: RFA HG 12 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,500,000 |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Apply for PA 12 171 Funding Number: PA 12 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Pre Application for the FY13 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 12 164 Funding Number: PAR 12 164 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| FY13 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 13 002 Funding Number: RFA DA 13 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01) Apply for RFA DA 13 007 Funding Number: RFA DA 13 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Synthesis and Preclinical Evaluation of Medications to Treat Substance Use Disorders (SUDs) (R01) Apply for RFA DA 13 004 Funding Number: RFA DA 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Health Information Technology for Broad Adoption by Healthcare Systems and Consumers (SBIR) (R44) Apply for PA 12 196 Funding Number: PA 12 196 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Groups (U10) Apply for RFA CA 12 007 Funding Number: RFA CA 12 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program Groups (U10) Apply for RFA CA 12 008 Funding Number: RFA CA 12 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIMH Career Transition Award for Tenure Track and Tenured Intramural Investigators (K22) Apply for PAR 12 201 Funding Number: PAR 12 201 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 144", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.